Some issues for the consideration of individual bioequivalence

DOI10.1080/10543409708835167MaRDI QIDQ4239496zbMATH OpenOpenAlexWikidataFDO

Authors Laszlo Endrenyi

Publication date 1997

Published in Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/10543409708835167

zbMATH Keywords

drug regulationdrug substitutionintrasubject variation

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• Assessment of Individual and Population Bioequivalence Using the Probability That Bioavailabilities are Similar
• Extension to the use of tolerance intervals for the assessment of individual bioequivalence
• Individual bioequivalence—a regulatory update
• Moment-based criteria for determining bioequivalence

This page was built for publication: Some issues for the consideration of individual bioequivalence

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4239496)